[go: up one dir, main page]

KR850001204A - 1,4-디하이드로피리딘 유도체의 제조방법 - Google Patents

1,4-디하이드로피리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR850001204A
KR850001204A KR1019840004336A KR840004336A KR850001204A KR 850001204 A KR850001204 A KR 850001204A KR 1019840004336 A KR1019840004336 A KR 1019840004336A KR 840004336 A KR840004336 A KR 840004336A KR 850001204 A KR850001204 A KR 850001204A
Authority
KR
South Korea
Prior art keywords
general formula
following general
group
nitro
hydrogen
Prior art date
Application number
KR1019840004336A
Other languages
English (en)
Inventor
로베르트 하이커 프레트 (외 5)
Original Assignee
권터 페터스·카를-루트비히 쉬미트
바이엘 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 권터 페터스·카를-루트비히 쉬미트, 바이엘 아크티엔 게젤샤프트 filed Critical 권터 페터스·카를-루트비히 쉬미트
Publication of KR850001204A publication Critical patent/KR850001204A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용 없음

Description

1,4-디하이드로피리딘 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 일반식(II)의 아미노크로톤산 에스테르를 다음 일반식(III)의 벤즈알데히드 및 다음 구조식(1)의 니트로아세톤과 반응시키거나, 다음 일반식(III)의 벤즈알데히드를 다음 일반식(IV)의 아세토 아세트산 에스테르와, 또는 다음 일반식(V)의 그의 크네베나겔 축합반응 생성물을 다음 구조식(2)의 니트로 아세톤 및 암모니아의 부가화합물과 반응시키거나, 다음 일반식(II)의 아미노 크로톤산 에스테르를 다음 일반식(VI)의 벤질리덴니트로아세톤과 반응시킴을 특징으로 하여 다음 일반식(I)의 1,4-디하이드로피리딘유도체 및 그의 약제학적으로 무독한 부가염을 제조하는 방법.
    상기식에서, R1및 R2는 같거나 다를 수 있으며, 수소, C1내지 C4-알킬, C1내지 C12알콕시, C1내지 C4-할로게노알콕시, 할로겐, 니트로, C1내지 C4-할로게노알킬, C1내지 C4-할로게노 알킬머캡토 또는 그룹 -Z-CH2 또는 -Z-CH2 [여기에서 Z는 산소 또는 황을 나타내고, R4및 R5는 같거나 다를 수 있으며, 수소, C1내지 C4-알킬, C1내지 C6-알콕시, 할로겐, C1내지 C4-할로게노알킬, C1내지 C4-할로게노알콕시 또는 니트로를 나타낸다]중의 하나를 나타내거나 R1및 R2는 페닐고리의 2개의 탄소원자와 함께 고리를 형성하고, X는 산소, 황 또는 라디칼 NR6[여기에서, R6는 C1내지 C6-알킬그룹을 나타낸다]를 나타내고, A는 C2내지 C10-알킬렌그룹 여기에서, 적어도 두 개의 탄소원자는 카복실그룹을 X에 연결시키는 알킬렌 사슬에 위치해야 한다]을 나타내고, R3는 적합하게는 탄수화물 화학에서 통상적인 보호그룹으로 보호된 모노 사카라이드 또는 디사카라이드 잔기를 나타낸다.
  2. 제1항에 있어서, R1은 수소를 나타내고, R2는 할로겐, 트리플루오로 메틸, 니트로, 수소 또는 그룹 -X-CH2 또는[여기에서, R4및 R5는 제1항에서 정의한 것과 같다] 중의 하나를 나타내고, X는 산소 또는 황을 나타내고, A는 C2내지 C4-알킬렌그룹을 나타내고, R3는 적합하게는 보호그룹으로 보호된 모노사카라이드 잔기를 나타내는 제조방법.
  3. 제1항에 있어서, 희석제를 사용함을 특징으로 하는 방법.
  4. 제1항에 있어서, 반응을 20 내지 150℃의 온도에서 수행하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004336A 1983-07-22 1984-07-21 1,4-디하이드로피리딘 유도체의 제조방법 KR850001204A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833326384 DE3326384A1 (de) 1983-07-22 1983-07-22 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DEP3326384.1 1983-07-22

Publications (1)

Publication Number Publication Date
KR850001204A true KR850001204A (ko) 1985-03-16

Family

ID=6204598

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004336A KR850001204A (ko) 1983-07-22 1984-07-21 1,4-디하이드로피리딘 유도체의 제조방법

Country Status (14)

Country Link
US (1) US4537881A (ko)
EP (1) EP0139859B1 (ko)
JP (1) JPS6042393A (ko)
KR (1) KR850001204A (ko)
AT (1) ATE38041T1 (ko)
AU (1) AU564069B2 (ko)
CA (1) CA1229590A (ko)
DE (2) DE3326384A1 (ko)
ES (3) ES534508A0 (ko)
GR (1) GR82104B (ko)
HU (1) HUT36092A (ko)
IL (1) IL72454A (ko)
PT (1) PT78947B (ko)
ZA (1) ZA845626B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT39179A (en) * 1984-12-10 1986-08-28 Sandoz Ag Process for production of derivatives of 1,4-dihydro-piridin
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
JPH02167262A (ja) * 1988-06-05 1990-06-27 Taisho Pharmaceut Co Ltd 1,4―ジヒドロピリジン誘導体
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
GB9119983D0 (en) * 1991-09-19 1991-11-06 Erba Carlo Spa Dihydropyridine derivatives useful in antitumor therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2641746C2 (de) * 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0139859B1 (de) 1988-10-19
ES543741A0 (es) 1986-01-16
HUT36092A (en) 1985-08-28
US4537881A (en) 1985-08-27
ATE38041T1 (de) 1988-11-15
ES543742A0 (es) 1986-01-16
CA1229590A (en) 1987-11-24
ES8602662A1 (es) 1985-12-01
DE3326384A1 (de) 1985-01-31
DE3474669D1 (en) 1988-11-24
PT78947B (en) 1986-06-02
AU3088784A (en) 1985-01-24
ES8604150A1 (es) 1986-01-16
IL72454A (en) 1987-11-30
EP0139859A3 (en) 1986-08-20
PT78947A (en) 1984-08-01
IL72454A0 (en) 1984-11-30
ZA845626B (en) 1985-03-27
ES8604149A1 (es) 1986-01-16
ES534508A0 (es) 1985-12-01
EP0139859A2 (de) 1985-05-08
JPS6042393A (ja) 1985-03-06
AU564069B2 (en) 1987-07-30
GR82104B (ko) 1984-12-13

Similar Documents

Publication Publication Date Title
KR870007163A (ko) 질소함유 융합 헤테로 사이클릭 화합물의 제조방법
KR840005718A (ko) 오메프라졸 중간체의 제조방법
ES2000910A6 (es) Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos
KR840007011A (ko) 세펨 화합물의 제조방법
KR860000248A (ko) N-아실 산성 아미노산 디아미드 유도체의 제조방법
KR850001204A (ko) 1,4-디하이드로피리딘 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
KR880701234A (ko) 신규 비페닐 유도체와 그의 제조 방법 및 용도
KR840006206A (ko) 이소퀴놀린 유도체의 제조방법
KR860003259A (ko) 벤젠-융합 복소환 화합물의 제조방법
EP0277599A3 (en) Fluorine containing cyclopentane derivatives and processes for their production
KR890012931A (ko) 4-데메톡시다우노루비신의 아글리콘인 4-데메톡시다우노마이시논의 제조방법
KR840000521A (ko) 3-메틸플라본-8-카르복실산 에스테르류의 제조방법
PT83858A (de) Verfahren zur herstellung von cefodizim
KR840005107A (ko) 피리미디온 및 그의 산부가염의 제조방법
EP0342599A3 (en) Polyacetyl oligosaccharide derivatives
KR870002049A (ko) 6-치환된 안드로스타-1,4-디엔-3,7-디온 유도체의 제조 방법
KR870002151A (ko) 3,7-이치환된 -3- 세펨 화합물의 제조방법
KR850002101A (ko) 7-옥소-4-티아-1-아자비사이클로[3,2,0]헵트-엔-유도체의 제조방법
KR900003178A (ko) 세펨 화합물의 제조방법
KR860000295A (ko) 옥시캄 유도체의 제조방법
KR870002110A (ko) 구아니디노티아졸 유도체의 제조방법
KR840005815A (ko) I-옥사세팜 화합물의 제조방법
KR870000290A (ko) 치환된 우레아의 제조방법
KR910016673A (ko) 히드록시페닐프로피오네이트의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19840721

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19890721

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19840721

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19910911

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19911122

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19910911

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I